Literature DB >> 28031361

Severe Symptomatic Primary Human Cytomegalovirus Infection despite Effective Innate and Adaptive Immune Responses.

Raphaëlle Riou1,2, Céline Bressollette-Bodin3,4,5, David Boutoille6, Katia Gagne1,2,7,8, Audrey Rodallec5, Maeva Lefebvre6, François Raffi6, David Senitzer9, Berthe-Marie Imbert-Marcille3,4,5, Christelle Retière10,2.   

Abstract

Primary human cytomegalovirus (HCMV) infection usually goes unnoticed, causing mild or no symptoms in immunocompetent individuals. However, some rare severe clinical cases have been reported without investigation of host immune responses or viral virulence. In the present study, we investigate for the first time phenotypic and functional features, together with gene expression profiles in immunocompetent adults experiencing a severe primary HCMV infection. Twenty primary HCMV-infected patients (PHIP) were enrolled, as well as 26 HCMV-seronegative and 39 HCMV-seropositive healthy controls. PHIP had extensive lymphocytosis marked by massive expansion of natural killer (NK) and T cell compartments. Interestingly, PHIP mounted efficient innate and adaptive immune responses with a deep HCMV imprint, revealed mainly by the expansion of NKG2C+ NK cells, CD16+ Vδ2(-) γδ T cells, and conventional HCMV-specific CD8+ T cells. The main effector lymphocytes were activated and displayed an early immune phenotype that developed toward a more mature differentiated status. We suggest that both massive lymphocytosis and excessive lymphocyte activation could contribute to massive cytokine production, known to mediate tissue damage observed in PHIP. Taken together, these findings bring new insights into the comprehensive understanding of immune mechanisms involved during primary HCMV infection in immunocompetent individuals.IMPORTANCE HCMV-specific immune responses have been extensively documented in immunocompromised patients and during in utero acquisition. While it usually goes unnoticed, some rare severe clinical cases of primary HCMV infection have been reported in immunocompetent patients. However, host immune responses or HCMV virulence in these patients has not so far been investigated. In the present study, we show massive expansion of NK and T cell compartments during the symptomatic stage of acute HCMV infection. The patients mounted efficient innate and adaptive immune responses with a deep HCMV imprint. The massive lymphocytosis could be the result of nonadapted or uncontrolled immune responses limiting the effectiveness of the specific responses mounted. Both massive lymphocytosis and excessive lymphocyte activation could contribute to massive cytokine production, known to mediate tissue damage. Furthermore, we cannot exclude a delayed immune response caused by immune escape established by HCMV strains.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  HCMV; NK cells; T lymphocytes; adaptive immunity; innate immunity

Mesh:

Year:  2017        PMID: 28031361      PMCID: PMC5309965          DOI: 10.1128/JVI.02245-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.

Authors:  Sandra Lopez-Vergès; Jeffrey M Milush; Brian S Schwartz; Marcelo J Pando; Jessica Jarjoura; Vanessa A York; Jeffrey P Houchins; Steve Miller; Sang-Mo Kang; Phillip J Norris; Douglas F Nixon; Lewis L Lanier
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

2.  Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children.

Authors:  Adriana Monsiváis-Urenda; Daniel Noyola-Cherpitel; Alba Hernández-Salinas; Christian García-Sepúlveda; Neus Romo; Lourdes Baranda; Miguel López-Botet; Roberto González-Amaro
Journal:  Eur J Immunol       Date:  2010-05       Impact factor: 5.532

3.  IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion.

Authors:  Alexander Rölle; Julia Pollmann; Eva-Maria Ewen; Vu Thuy Khanh Le; Anne Halenius; Hartmut Hengel; Adelheid Cerwenka
Journal:  J Clin Invest       Date:  2014-11-10       Impact factor: 14.808

4.  Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education.

Authors:  Niklas K Björkström; Peggy Riese; Frank Heuts; Sandra Andersson; Cyril Fauriat; Martin A Ivarsson; Andreas T Björklund; Malin Flodström-Tullberg; Jakob Michaëlsson; Martin E Rottenberg; Carlos A Guzmán; Hans-Gustaf Ljunggren; Karl-Johan Malmberg
Journal:  Blood       Date:  2010-08-09       Impact factor: 22.113

5.  Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation.

Authors:  Mark Cook; David Briggs; Charles Craddock; Premini Mahendra; Donald Milligan; Christopher Fegan; Philip Darbyshire; Sarah Lawson; Elizabeth Boxall; Paul Moss
Journal:  Blood       Date:  2005-10-20       Impact factor: 22.113

6.  Major expansion of gammadelta T lymphocytes following cytomegalovirus infection in kidney allograft recipients.

Authors:  J Déchanet; P Merville; F Bergé; G Bone-Mane; J L Taupin; P Michel; P Joly; M Bonneville; L Potaux; J F Moreau
Journal:  J Infect Dis       Date:  1999-01       Impact factor: 5.226

7.  Imprint of human cytomegalovirus infection on the NK cell receptor repertoire.

Authors:  Mónica Gumá; Ana Angulo; Carlos Vilches; Natalia Gómez-Lozano; Núria Malats; Miguel López-Botet
Journal:  Blood       Date:  2004-08-10       Impact factor: 22.113

Review 8.  AID and APOBECs span the gap between innate and adaptive immunity.

Authors:  Arnaud Moris; Shannon Murray; Sylvain Cardinaud
Journal:  Front Microbiol       Date:  2014-10-13       Impact factor: 5.640

9.  Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children.

Authors:  Shamanthi Jayasooriya; Thushan I de Silva; Jainaba Njie-jobe; Chilel Sanyang; Alison M Leese; Andrew I Bell; Karen A McAulay; Peng Yanchun; Heather M Long; Tao Dong; Hilton C Whittle; Alan B Rickinson; Sarah L Rowland-Jones; Andrew D Hislop; Katie L Flanagan
Journal:  PLoS Pathog       Date:  2015-03-27       Impact factor: 6.823

10.  Mature CD8(+) T lymphocyte response to viral infection during fetal life.

Authors:  Arnaud Marchant; Victor Appay; Marianne Van Der Sande; Nicolas Dulphy; Corinne Liesnard; Michael Kidd; Steve Kaye; Olubukola Ojuola; Geraldine M A Gillespie; Ana L Vargas Cuero; Vincenzo Cerundolo; Margaret Callan; Keith P W J McAdam; Sarah L Rowland-Jones; Catherine Donner; Andrew J McMichael; Hilton Whittle
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

View more
  8 in total

1.  Cell type-specific biogenesis of novel vesicles containing viral products in human cytomegalovirus infection.

Authors:  Samina Momtaz; Belen Molina; Luwanika Mlera; Felicia Goodrum; Jean M Wilson
Journal:  J Virol       Date:  2021-03-24       Impact factor: 5.103

Review 2.  Cytokine-Mediated Tissue Injury in Non-human Primate Models of Viral Infections.

Authors:  Cordelia Manickam; Spandan V Shah; Olivier Lucar; Daniel R Ram; R Keith Reeves
Journal:  Front Immunol       Date:  2018-12-04       Impact factor: 7.561

3.  Shared Molecular Signatures Across Neurodegenerative Diseases and Herpes Virus Infections Highlights Potential Mechanisms for Maladaptive Innate Immune Responses.

Authors:  Ana Caroline Costa Sa; Heather Madsen; James R Brown
Journal:  Sci Rep       Date:  2019-06-19       Impact factor: 4.379

Review 4.  Generation, maintenance and tissue distribution of T cell responses to human cytomegalovirus in lytic and latent infection.

Authors:  Sarah E Jackson; George X Sedikides; Georgina Okecha; Mark R Wills
Journal:  Med Microbiol Immunol       Date:  2019-03-20       Impact factor: 3.402

Review 5.  The CD4+ T Cell Response to Human Cytomegalovirus in Healthy and Immunocompromised People.

Authors:  Eleanor Y Lim; Sarah E Jackson; Mark R Wills
Journal:  Front Cell Infect Microbiol       Date:  2020-05-19       Impact factor: 5.293

Review 6.  CMV-Specific Cell-Mediated Immunity in Immunocompetent Adults with Primary CMV Infection: A Case Series and Review of the Literature.

Authors:  Angela Chiereghin; Gabriella Verucchi; Tiziana Lazzarotto
Journal:  Viruses       Date:  2021-05-01       Impact factor: 5.048

Review 7.  CD1-Restricted T Cells During Persistent Virus Infections: "Sympathy for the Devil".

Authors:  Günther Schönrich; Martin J Raftery
Journal:  Front Immunol       Date:  2018-03-19       Impact factor: 7.561

8.  Advances in the treatment of cytomegalovirus.

Authors:  B A Krishna; M R Wills; J H Sinclair
Journal:  Br Med Bull       Date:  2019-09-19       Impact factor: 4.291

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.